Search

everythinglearnresearchcommunity

for

Search:↓

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Certain substances can strongly inhibit DNA synthesis in hair cells.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

BTNL2 helps protect hair follicles from immune attacks.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

MC-1R in skin cells may influence inflammation and collagen production.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.